Neueste SCI Publikationen

Dobersberger, M; Maltrovsky, L; Sumesgutner, D; Zajc, C; Salzer, B; Laurent, E; Emminger, D; Sylvander, E; Lehner, E; Teufl, M; Seigner, J; Bobbili, M; Kunert, R; Lehner, M; Traxlmayr, M
(2026): ENGINEERING CAR T CELLS TO TARGET LIGAND-ACTIVATED EGFR
Dobersberger M, Maltrovsky L, Sumesgutner D, Zajc C, Salzer B, Laurent E, et al. ENGINEERING CAR T CELLS TO TARGET LIGAND-ACTIVATED EGFR. Human Gene Therapy. 2026;37(1_SUPPL):39S-39S.
Taschauer, A; Egger, D; Sedivy, A; Crousilles, A; Wunder, C; Waldstein, SM
(2026): Preserved structural and functional stability of high-dose aflibercept after compounding into prefilled syringes
Taschauer A, Egger D, Sedivy A, Crousilles A, Wunder C, Waldstein S. Preserved structural and functional stability of high-dose aflibercept after compounding into prefilled syringes. Scientific Reports. 2026;16(1):31572. doi:https://doi.org/10.1038/s41598-026-61511-9
Pranomphon, R; Sharfstein, ST; Yamabhai, M; Grünwald-Gruber, C
(2026): Impact of Copper and Melezitose Supplementation on Adalimumab Production and N-linked Glycosylation in Chinese Hamster Ovary Cell Culture
Pranomphon R, Sharfstein S, Yamabhai M, Grünwald-Gruber C. Impact of Copper and Melezitose Supplementation on Adalimumab Production and N-linked Glycosylation in Chinese Hamster Ovary Cell Culture. Chiang Mai Journal of Science. 2026;53(5):e2026080. doi:https://doi.org/10.12982/CMJS.2026.080
Alle Publikationen finden Sie im FIS